Healwell AI (DB:6H90) - Aktienkurs, Nachrichten und Analyse

6H90 Aktienübersicht

Healwell AI Inc. ist ein Technologieunternehmen im Gesundheitswesen, das sich auf KI und Data Science für die präventive Pflege konzentriert.

Über das Unternehmen

6H90 grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	0/6
Künftiges Wachstum	2/6
Vergangene Leistung	0/6
Finanzielle Gesundheit	5/6
Dividenden	0/6

Belohnungen

Prognostiziertes jährliches Umsatzwachstum 58.95%

Risikoanalyse

Die Aktionäre wurden im vergangenen Jahr erheblich verwässert

Stark schwankender Aktienkurs in den letzten 3 Monaten

Derzeit unrentabel und in den nächsten 3 Jahren nicht rentabel zu werden prognostiziert

Healwell AI Inc. Wettbewerber

VITA 34

XTRA:V3V

€83.0m

SYNLAB

XTRA:SYAB

€2.5b

Fresenius Medical Care

XTRA:FME

€10.4b

Fresenius SE KGaA

XTRA:FRE

€15.8b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Healwell AI
Historische Aktienkurse
Aktueller Aktienkurs	CA$1.60
52-Wochen-Hoch	CA$2.43
52-Wochen-Tief	CA$0.083
Beta	-0.81
11 Monat Veränderung	36.75%
3 Monate Veränderung	164.46%
1 Jahr Veränderung	1,395.33%
33 Jahre Veränderung	n/a
5 Jahre Veränderung	n/a
Veränderung seit IPO	-14.88%

Aktuelle Nachrichten und Updates

Recent updates

Aktionärsrenditen

	6H90	DE Healthcare	DE Markt
7D	-16.2%	-5.4%	0.008%
1Y	1,395.3%	-1.5%	3.1%

Rendite im Vergleich zur Industrie: 6H90 übertraf die Branche German Healthcare , die im vergangenen Jahr eine Rendite von 1.8 erzielte.

Rendite vs. Markt: 6H90 übertraf den Markt German, der im vergangenen Jahr eine Rendite von 1.7 erzielte.

Preisvolatilität

Is 6H90's price volatile compared to industry and market?
6H90 volatility
6H90 Average Weekly Movement	17.3%
Healthcare Industry Average Movement	5.4%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	10.4%
10% least volatile stocks in DE Market	2.6%

Stabiler Aktienkurs: 6H90Der Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: 6H90Die wöchentliche Volatilität (17%) war im vergangenen Jahr stabil, liegt aber immer noch höher als bei 75 % der German Aktien.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2012	102	Alex Dobranowski	www.healwell.ai

Healwell AI Inc. ist ein Technologieunternehmen im Gesundheitswesen, das sich auf KI und Data Science für die präventive Pflege konzentriert. Es bietet eine KI-gestützte Plattform zur Entscheidungsunterstützung für Gesundheitsdienstleister. Healwell AI Inc. hat eine strategische Allianz mit WELL Health Technologies Corp. geschlossen, um das Wachstum und die Entwicklung von KI-gestützten Gesundheitstechnologien zu fördern.

Healwell AI Inc.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Healwell AI im Vergleich zum Marktanteil des Unternehmens?
6H90 grundlegende Statistiken
Marktanteil	€207.10m
Gewinn(TTM)	-€21.40m
Umsatz(TTM)	€6.78m

30.6x

Kurs-Umsatz-Verhältnis

-9.7x

Kurs-Gewinn-Verhältnis

Ist 6H90 zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
6H90 Gewinn- und Verlustrechnung (TTM)
Einnahmen	CA$9.92m
Kosten der Einnahmen	CA$6.78m
Bruttogewinn	CA$3.14m
Sonstige Ausgaben	CA$34.48m
Umsatz	-CA$31.34m

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	-0.24
Bruttomarge	31.68%
Nettogewinnspanne	-315.87%
Schulden/Eigenkapital-Verhältnis	68.4%

Wie hat sich 6H90 auf lange Sicht entwickelt?

Historische Performance und Vergleiche

6H90 Aktienübersicht

Belohnungen

Risikoanalyse

Healwell AI Inc. Wettbewerber

XTRA:V3V

€83.0m

XTRA:SYAB

€2.5b

XTRA:FME

€10.4b

XTRA:FRE

€15.8b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Healwell AI Inc. (TSX:AIDX) agreed to acquire VeroSource Solutions Inc. for CAD 24.5 million on June 11, 2024.

Healwell AI Inc. Announces Chief Financial Officer Changes

Healwell AI Inc. announced that it has received CAD 20.00025 million in funding

First quarter 2024 earnings released: CA$0.06 loss per share (vs CA$0.14 loss in 1Q 2023)

Recent updates

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Healwell AI Inc. (TSX:AIDX) agreed to acquire 100% stake in Bio Pharma Services Inc. from Think Research Corporation for CAD 14.4 million.

Healwell AI Inc. (TSX:AIDX) agreed to acquire VeroSource Solutions Inc. for CAD 24.5 million on June 11, 2024.

Healwell AI Inc. Announces Chief Financial Officer Changes

Healwell AI Inc. announced that it has received CAD 20.00025 million in funding

First quarter 2024 earnings released: CA$0.06 loss per share (vs CA$0.14 loss in 1Q 2023)

Healwell AI Inc. to Report Q1, 2024 Results on May 14, 2024

Healwell AI Inc. announced that it expects to receive CAD 16.000065 million in funding

Healwell AI Inc., Annual General Meeting, Jun 25, 2024

Healwell AI Inc., Annual General Meeting, Jun 12, 2024

Full year 2023 earnings released: CA$0.56 loss per share (vs CA$0.42 loss in FY 2022)

Healwell AI Inc. to Report Q4, 2023 Results on Mar 28, 2024

Healwell AI Inc. Announces Executive Changes

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

New major risk - Shareholder dilution

Healwell AI Inc. has completed a Composite Units Offering.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of an unknown majority stake in Pentavere Research Group Inc. Christopher Pettengell, Aviva Pratzer, Mark Harris, Steven Aviv, Hilton Silberg, AAron Leibtag and others.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire an unknown stake in Pentavere Research Group Inc. for CAD 5.9 million.

Third quarter 2023 earnings released: CA$0.14 loss per share (vs CA$0.18 loss in 3Q 2022)

Healwell Ai Inc. Appoints Mark Findlay as Senior Vice President of Sales and Marketing for Canada

Healwell AI Inc. to Report Q3, 2023 Results on Nov 15, 2023

Healwell AI Inc. announced that it has received CAD 3.00024 million in funding

Less than half of directors are independent

Healwell Al Inc. Announces Board and Executive Changes

High number of new and inexperienced directors

MCI Onehealth Technologies Inc. Announces Sven Grail and George Christodoulou, the Former Co-Chairs, Did Not Stand for Re-Election

New major risk - Negative shareholders equity

Second quarter 2023 earnings released: CA$0.21 loss per share (vs CA$0.084 loss in 2Q 2022)

MCI Onehealth Technologies Inc., Annual General Meeting, Sep 21, 2023

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

WELL Health Technologies Corp. (TSX:WELL) entered into a definitive share purchase agreement to acquire MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR) for CAD 2 million.

MCI Onehealth Technologies Inc. announced that it has received CAD 1.5 million in funding

First quarter 2023 earnings released: CA$0.15 loss per share (vs CA$0.086 loss in 1Q 2022)

MCI Onehealth Technologies Inc. Announces Changes to Management Team Structure

High number of new and inexperienced directors

MCI Onehealth Technologies Inc. to Report Q3, 2022 Results on Nov 14, 2022

MCI Onehealth Technologies Inc. Expands Data Insights Offering with Innovative AI-driven Continuing Medical Education

Second quarter 2022 earnings released: CA$0.084 loss per share (vs CA$0.058 loss in 2Q 2021)

MCI Onehealth Technologies Inc. to Report Q2, 2022 Results on Aug 15, 2022

MCI Onehealth Technologies Inc. Provides Revenue Guidance for the Year 2022

First quarter 2022 earnings released: CA$0.084 loss per share (vs CA$0.054 loss in 1Q 2021)

MCI Onehealth Technologies Inc. to Report Q1, 2022 Results on May 16, 2022

Less than half of directors are independent

MCI Onehealth Technologies Inc., Annual General Meeting, Jun 17, 2022

Full year 2021 earnings released: CA$0.33 loss per share (vs CA$0.027 loss in FY 2020)

MCI Onehealth Technologies Inc. Provides Revenue Guidance for Fiscal 2022

MCI Onehealth Appoints Jennifer Foster as Chief Operating Officer with Mandate to Support Expansion of Tech and Data Offerings

Third quarter 2021 earnings released: CA$0.11 loss per share

Co-Founder & Co-Executive Chair recently bought €58k worth of stock

Second quarter 2021 earnings released

MCI Onehealth Technologies Inc. (TSX:DRDR) acquired a 9% stake in ReGen Scientific Inc.

Aktionärsrenditen

Preisvolatilität

Über das Unternehmen

Healwell AI Inc.'s Grundlagenzusammenfassung

30.6x

-9.7x

Erträge & Einnahmen